Literature DB >> 18092352

The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells.

Shilajit D Kundu1, Chung Lee, Benjamin K Billips, Geoffrey M Habermacher, Qiang Zhang, Victoria Liu, Larry Y Wong, David J Klumpp, Praveen Thumbikat.   

Abstract

BACKGROUND: Inflammation and infection have been linked to the pathogenesis of many cancers including prostate cancer. Components of bacteria and viruses have been identified within pathological specimens of men with prostate cancer.
METHODS: We characterized the in vitro response of benign prostate epithelial cells to components of infectious agents as they relate to toll-like receptors.
RESULTS: Primary and immortalized prostate epithelial cells (RWPE) exhibited increased proliferation in response to exposure to lipopolysaccharide (LPS) and CpG DNA. These molecules are well-characterized surrogates for gram negative bacteria (e.g., E. coli) and DNA viruses (e.g., HPV and HSV), which are common in the genitourinary system. Our experiments show that RWPE cells express both TLR 4 (LPS-specific) and TLR 9 (CpG-specific). Targeted knock down of individual TLR expression using siRNA abrogated the proliferative response of RWPE cells to LPS and CpG, respectively. In addition, compared to non-stimulated cells, LPS and CpG up-regulate active NF-kB expression. Increased NF-kB activation was confirmed using RWPE cells that were stably transfected with a NF-kB reporter construct. Interestingly, NF-kB activation was both concentration- and time-dependent when stimulated with LPS. RWPE cells were less susceptible to TNF-alpha induced apoptosis as measured by TUNEL staining when stimulated with CpG or LPS. High concentrations of LPS also prevented cell death as measured by LDH release.
CONCLUSIONS: Our study has identified a unique mechanism that describes how components of pathogens common in the urinary system may contribute to the malignant transformation of benign prostate epithelia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18092352     DOI: 10.1002/pros.20710

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  61 in total

Review 1.  Role of TLR2-dependent inflammation in metastatic progression.

Authors:  Sunhwa Kim; Michael Karin
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

Review 2.  Important aspects of Toll-like receptors, ligands and their signaling pathways.

Authors:  Z L Chang
Journal:  Inflamm Res       Date:  2010-07-01       Impact factor: 4.575

3.  Prostate secretions from men with chronic pelvic pain syndrome inhibit proinflammatory mediators.

Authors:  Praveen Thumbikat; Shiva Shahrara; Rudina Sobkoviak; Joseph Done; Richard M Pope; Anthony J Schaeffer
Journal:  J Urol       Date:  2010-08-17       Impact factor: 7.450

4.  Association of Toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian population.

Authors:  Raju K Mandal; Ginu P George; Rama D Mittal
Journal:  Mol Biol Rep       Date:  2012-02-06       Impact factor: 2.316

5.  Inflammation and cancer.

Authors:  Noemí Eiró; Francisco J Vizoso
Journal:  World J Gastrointest Surg       Date:  2012-03-27

6.  Toll-like receptor 9 activation by CpG oligodeoxynucleotide 7909 enhances the radiosensitivity of A549 lung cancer cells via the p53 signaling pathway.

Authors:  Sujuan Yuan; Tiankui Qiao; Xuan Li; Xibing Zhuang; Wei Chen; Xue Chen; Qi Zhang
Journal:  Oncol Lett       Date:  2018-01-31       Impact factor: 2.967

7.  Lipopolysaccharide Domains Modulate Urovirulence.

Authors:  Lizath M Aguiniga; Ryan E Yaggie; Anthony J Schaeffer; David J Klumpp
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

8.  Squamous carcinoma cells influence monocyte phenotype and suppress lipopolysaccharide-induced TNF-alpha in monocytes.

Authors:  Aroonwan Lam-ubol; Dustin Hopkin; Elena M Letuchy; Zoya B Kurago
Journal:  Inflammation       Date:  2010-08       Impact factor: 4.092

9.  High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer.

Authors:  E L Wang; Z R Qian; M Nakasono; T Tanahashi; K Yoshimoto; Y Bando; E Kudo; M Shimada; T Sano
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

10.  Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment.

Authors:  Yusuke Sato; Yasufumi Goto; Norihiko Narita; Dave S B Hoon
Journal:  Cancer Microenviron       Date:  2009-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.